Literature DB >> 2165801

Mucinous adenocarcinoma metastatic to the iris, ciliary body, and choroid.

W E Lieb1, J A Shields, C L Shields, G L Spaeth.   

Abstract

A 67-year-old woman presented with signs of severe intraocular inflammation and secondary glaucoma. The initial diagnosis was uveitis, and an anterior chamber paracentesis with cytological study of the aspirate failed to establish an aetiological diagnosis. After three trabeculectomies had failed to control the intraocular pressure, the blind eye was enucleated. On histopathological examination a mucinous adenocarcinoma was found to cover diffusely the iris surface and to involve the ciliary body and peripheral choroid. The patient subsequently developed evidence of widespread metastatic disease and died shortly thereafter. Although a primary tumour was never found, histochemical and immunohistochemical studies of the enucleated eye suggested that the lesion originated in the gastrointestinal tract. In cases of intractable glaucoma and anterior chamber inflammation, metastatic carcinoma should be included in the differential diagnosis, and efforts should be made to substantiate the diagnosis by a systemic examination or a biopsy.

Entities:  

Mesh:

Year:  1990        PMID: 2165801      PMCID: PMC1042133          DOI: 10.1136/bjo.74.6.373

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  24 in total

1.  Carcinoma metastatic to the eye and orbit II. A clinicopathological study of 26 patients with carcinoma metastatic to the anterior segment of the eye.

Authors:  A P Ferry; R L Font
Journal:  Arch Ophthalmol       Date:  1975-07

2.  Iris metastasis from a bronchial carcinoid tumor.

Authors:  M Rodrigues; J A Shields
Journal:  Arch Ophthalmol       Date:  1978-01

3.  Carcinoma metastatic to the eye and orbit. I. A clinicopathologic study of 227 cases.

Authors:  A P Ferry; R L Font
Journal:  Arch Ophthalmol       Date:  1974-10

4.  Metastatic carcinoma of the ciliary body simulating uveitis. Diagnosis by cytologic examination of aqueous humor.

Authors:  W E Morgan; R A Malmgren; D M Albert
Journal:  Arch Ophthalmol       Date:  1970-01

5.  The remarkable polymorphism of tumours of the ciliary epithelium.

Authors:  L E Zimmerman
Journal:  Trans Aust Coll Ophthalmol       Date:  1970

6.  Carcinoembryonic antigen-positive metastatic adenocarcinoma of the choroid. A case report.

Authors:  J B Michelson; N T Felberg; J A Shields; L Foster
Journal:  Arch Ophthalmol       Date:  1975-09

7.  Diagnosis and management of cancer metastatic to the uvea: a study of 70 cases.

Authors:  R F Stephens; J A Shields
Journal:  Ophthalmology       Date:  1979-07       Impact factor: 12.079

8.  Metastatic carcinoma of the iris.

Authors:  T R Freeman; A H Friedman
Journal:  Am J Ophthalmol       Date:  1975-11       Impact factor: 5.258

9.  Carcinoembryonic antigen. Its role in the evaluation of intraocular malignant tumors.

Authors:  J B Michelson; N T Felberg; J A Shields
Journal:  Arch Ophthalmol       Date:  1976-03

10.  Metastatic adenocarcinoma to the anterior uvea and increased carcinoembryonic antigen levels.

Authors:  G T Denslow; R A Kielar
Journal:  Am J Ophthalmol       Date:  1978-03       Impact factor: 5.258

View more
  4 in total

Review 1.  Don't it make my blue eyes brown: heterochromia and other abnormalities of the iris.

Authors:  I G Rennie
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

Review 2.  Diagnostic vitrectomy for infectious uveitis.

Authors:  Abdallah Jeroudi; Steven Yeh
Journal:  Int Ophthalmol Clin       Date:  2014

3.  Papillary adenocarcinoma of ciliary body.

Authors:  Anup P Bhandari; Sunil Y Swami; Rasika U Gadkari
Journal:  Oman J Ophthalmol       Date:  2013-05

Review 4.  Ophthalmic Metastasis of Breast Cancer and Ocular Side Effects from Breast Cancer Treatment and Management: Mini Review.

Authors:  Ilias Georgalas; Theodore Paraskevopoulos; Chryssanthi Koutsandrea; Evgenia Kardara; Panagiotis Malamos; Dimitrios Ladas; Dimitris Papaconstantinou
Journal:  Biomed Res Int       Date:  2015-05-11       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.